TMIGD2 and osteosarcoma: Our results showed that the expressions of LAG3, HAVCR2, CD27, TNFRSF14, CTLA4, TMIGD2, TIGIT and PDCD1LG2 in low-risk osteosarcoma group were higher than those in high-risk group (Fig 6A–6H).